| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |